CERo Therapeutics Holdings Inc [NASDAQ: CERO] loss -29.40% or -0.4 points to close at $0.96 with a heavy trading volume of 5962844 shares.
The daily chart for CERO points out that the company has recorded -89.74% loss over the past six months.
If we look at the average trading volume of 666.55K shares, CERO reached to a volume of 5962844 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Trading performance analysis for CERO stock
CERo Therapeutics Holdings Inc [CERO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -34.23. With this latest performance, CERO shares dropped by -48.10% in over the last four-week period, additionally sinking by -89.74% over the last 6 months – not to mention a drop of -99.67% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CERO stock in for the last two-week period is set at 26.38, with the RSI for the last a single of trading hit 17.36, and the three-weeks RSI is set at 32.89 for CERo Therapeutics Holdings Inc [CERO]. The present Moving Average for the last 50 days of trading for this stock 2.4089, while it was recorded at 1.3140 for the last single week of trading, and 16.5371 for the last 200 days.
CERo Therapeutics Holdings Inc [CERO]: A deeper dive into fundamental analysis
CERo Therapeutics Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.39 and a Current Ratio set at 0.39.
An analysis of Institutional ownership at CERo Therapeutics Holdings Inc [CERO]
There are presently around $4.47%, or 5.50%% of CERO stock, in the hands of institutional investors.
